User:Mr. Ibrahem/Mavacamten

Mavacamten, sold under the brand name Camzyos, is a medication used to treat hypertrophic obstructive cardiomyopathy (HCOM). It is taken by mouth.

Common side effects include dizziness and syncope. Other side effects may include heart failure. Use in pregnancy may harm the baby. It is a cardiac myosin inhibitor.

Mavacamten was approved for medical use in the United States in 2022. It is not available in Europe or the United Kingdom as of 2022. In the United States a month of medication costs about 7,800 USD.